Showing results (91-100 of 129) with videos related to
Sort By:
Pageof 13
Blood|May 29, 2015
2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairmentAlister P W Funnell, Paolo Prontera, Valentina Ottaviani, et al.Molecular Diagnosis & Therapy|February 17, 2022
Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic DiseasesAntonino Giambona, Margherita Vinciguerra, Filippo Leto, et al.British Journal of Haematology|May 20, 2020
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort studyPaolo Ricchi, Antonella Meloni, Laura Pistoia, et al.Blood Cells, Molecules & Diseases|June 18, 2002
Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trialAurelio Maggio, Gennaro D'Amico, Alberto Morabito, et al.European Journal of Haematology|November 3, 2017
Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNETAngela Vitrano, Massimiliano Sacco, Rosamaria Rosso, et al.Current Medical Research and Opinion|May 5, 2017
Pattern of complications and burden of disease in patients affected by beta thalassemia majorFedele Bonifazi, Rosa Conte, Paola Baiardi, et al.Journal of Magnetic Resonance Imaging : JMRI|June 27, 2009
Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial ironAnna Ramazzotti, Alessia Pepe, Vincenzo Positano, et al.Haematologica|December 20, 2011
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infectionVito Di Marco, Fabrizio Bronte, Vincenza Calvaruso, et al.Blood Cells, Molecules & Diseases|May 1, 2013
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia majorAldo Filosa, Angela Vitrano, Paolo Rigano, et al.Blood Cells, Molecules & Diseases|August 17, 2011
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trialsAurelio Maggio, Aldo Filosa, Angela Vitrano, et al.Pageof 13